Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)
Price and Volume
Detailed Quote| Volume | 19,099,859 |
| Open | 3.690 |
| Bid (Size) | 3.560 (4,100) |
| Ask (Size) | 3.570 (1,400) |
| Prev. Close | 3.810 |
| Today's Range | 3.470 - 3.770 |
| 52wk Range | 2.770 - 5.240 |
| Shares Outstanding | 168,425,907 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
32.3% below 52-week high
3.550
2.7752W Low
5.2452W High
1 Week
11.5% below 1-week high
3.421W Low
4.011W High
Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) traded between $2.77 and $5.24 over the past 52 weeks and last traded at $3.55, 32.3% below its 52-week high. Over the past week it ranged between $3.42 and $4.01.
Past 12 Months
1W
-$0.33
1M
-$0.46
3M
+$0.20
6M
+$0.40
YTD
-$0.65
1Y
-$0.96
RXRX was -21.3% over the past year, +12.7% over six months, -15.5% year to date, -8.5% in the last week.
12 Months vs Market
RXRX
-21.3%
DIA
+10.1%
SPY
+10.0%
QQQ
+8.3%
IWM
+15.0%
Over the past 12 months RXRX returned -21.3% versus DIA (Dow) +10.1%, SPY (S&P 500) +10.0%, QQQ (Nasdaq 100) +8.3% and IWM (Russell 2000) +15.0%.
Volume & Liquidity
0.84× 3-mo avg
Today 19,099,859
3-mo avg 22.6M
1W
20.2M
1M
24.0M
3M
22.6M
6M
21.8M
YTD
19.6M
1Y
20.2M
RXRX most recently traded 19,099,859 shares against a 3-month average daily volume of 22.6M.
More News
Read More
Recursion Appoints Fred Hassan as Chair of the Board
November 02, 2026
1 Big Winner and 1 Loser From the Upcoming Anthropic IPO ↗
October 31, 2026
Next-Gen Biotech: RXRX, OCGN, SNTI, VIVS, ONCO Stocks to Watch
October 28, 2026
2 Beaten-Down Stocks to Avoid Right Now ↗
September 08, 2026
The Market Just Told You Which Layer Of AI Biology It Is Paying For
September 03, 2026
Recursion (RXRX) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Recursion Pharmaceuticals Q2 Earnings Call Highlights ↗
August 05, 2026
Recursion to Participate in Upcoming Investor Conferences
August 04, 2026
3 Stocks With the Most Upside by the End of 2026 ↗
July 30, 2026
2 Beaten-Down Stocks That Still Aren't Worth Buying ↗
July 11, 2026
Frequently Asked Questions
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.550
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 11/10/26 04:00 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 597.91M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 598M shares outstanding.